Microbiology Visit JGV Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 155 (2009), 4155-4169; DOI  10.1099/mic.0.027995-0IMMEDIATE OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Free Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary data
Right arrowOA All Versions of this Article:
mic.0.027995-0v1
155/12/4155    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brehony, C.
Right arrow Articles by Maiden, M. C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brehony, C.
Right arrow Articles by Maiden, M. C. J.
Agricola
Right arrow Articles by Brehony, C.
Right arrow Articles by Maiden, M. C. J.
Microbiology 155 (2009), 4155-4169; DOI  10.1099/mic.0.027995-0
© 2009 Society for General Microbiology

Variation of the factor H-binding protein of Neisseria meningitidis

Carina Brehony1, Daniel J. Wilson2 and Martin C. J. Maiden1

1 Department of Zoology, University of Oxford, OX1 3PS, UK
2 Department of Human Genetics, University of Chicago, 920 East 58th Street, CLSC #410, Chicago, IL 60637, USA

There is currently no comprehensive meningococcal vaccine, due to difficulties in immunizing against organisms expressing serogroup B capsules. To address this problem, subcapsular antigens, particularly the outer-membrane proteins (OMPs), are being investigated as candidate vaccine components. If immunogenic, however, such antigens are often antigenically variable, and knowledge of the extent and structuring of this diversity is an essential part of vaccine formulation. Factor H-binding protein (fHbp) is one such protein and is included in two vaccines under development. A survey of the diversity of the fHbp gene and the encoded protein in a representative sample of meningococcal isolates confirmed that variability in this protein is structured into two or three major groups, each with a substantial number of alleles that have some association with meningococcal clonal complexes and serogroups. A unified nomenclature scheme was devised to catalogue this diversity. Analysis of recombination and selection on the allele sequences demonstrated that parts of the gene are subject to positive selection, consistent with immune selection on the protein generating antigenic variation, particularly in the C-terminal region of the peptide sequence. The highest levels of selection were observed in regions corresponding to epitopes recognized by previously described bactericidal monoclonal antibodies.

Correspondence
Carina Brehony
carina.brehony{at}zoo.ox.ac.uk


Abbreviations: fH, factor H; fHbp, factor H-binding protein; {omega}, omega (dNdS); ST, sequence type

Two supplementary figures, showing distribution of clonal complexes within fHbp peptide alleles and a neighbour-joining tree constructed from aligned peptide sequences indicating association with clonal complex, are available with the online version of this paper.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.